DISCLAIMER: This product is strictly for research use only. It is meant solely for laboratory testing and in vitro studies-not for use in or on humans or animals. All details provided on this site are for educational purposes. This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such.
CJC-1295 (No DAC) + Ipamorelin + Tesamorelin (Blend)
CJC-1295 (no DAC), Ipamorelin, and Tesamorelin are studied together to boost natural growth hormone and IGF-1 levels through complementary pathways that support fat loss, recovery, and hormone balance.
Quantity: 1
All peptides arrive in powdered form for stability.
Third-Party Verified Purity
Each batch is tested and certified to meet or exceed 99% purity standards.
Made in the USA
Produced in United States WHO/GMP and ISO 9001:2015 certified facilities.
Rigorous Quality Control
Double-tested to ensure the highest quality for the most effective research.
What is CJC-1295 (No DAC) + Ipamorelin + Tesamorelin (Blend)?
CJC-1295 without Drug Affinity Complex (no DAC) is a short-acting analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary to release growth hormone (GH) in a natural, pulsatile pattern. Ipamorelin is a selective growth hormone secretagogue (GHS) that activates ghrelin receptors to increase GH secretion without significantly affecting cortisol or prolactin. Tesamorelin is a stabilized 44–amino acid GHRH analog that increases GH release and is FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. In research settings, this combination is explored for its potential to enhance GH output, IGF-1 production, and tissue recovery through multiple complementary pathways.
Potential Benefits Shown in Studies
Possible benefits of CJC‑1295 (no DAC) + Ipamorelin + Tesamorelin Blend:
- Maximized GH & IGF‑1 Release
- Accelerated Fat Loss, especially visceral adipose tissue
- Improved Sleep Quality & Mood
- Increased Energy & Cognitive Function
- Enhanced Cellular Repair & Regeneration
- Sustained, Natural GH Production
Mechanisms of Action
CJC-1295 (no DAC) + Ipamorelin + Tesamorelin may work together by:
- CJC-1295 (no DAC): Binding to GHRH receptors to produce short bursts of GH that mimic physiologic release
- Ipamorelin: Activating ghrelin receptors (GHS-R1a) to trigger GH release without large increases in cortisol or prolactin
- Tesamorelin: Stimulating GHRH receptors with a longer-acting profile, increasing GH secretion and promoting fat metabolism
- Increasing circulating IGF-1 to support protein synthesis, collagen formation, and tissue regeneration
- Supporting muscle preservation, fat utilization, and connective tissue health in research models
- Combining short-acting (CJC-1295 no DAC) and longer-acting (Tesamorelin) GHRH analogs for layered GH stimulation
Molecular Structure of Blend Components
CJC-1295 (No DAC) Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser
Molecular Properties
CJC-1295 (No DAC) + Ipamorelin + Tesamorelin (Blend) Research Highlights
Combining GHRH analogs (CJC‑1295, Tesamorelin) with a ghrelin receptor agonist (Ipamorelin) boosts growth hormone and IGF‑1 output via dual pathways.
Source: smithfieldtimes
Tesamorelin is FDA-approved for reducing visceral fat in HIV-associated lipodystrophy, with effects on abdominal adipose tissue confirmed in randomized controlled trials.
Source: jamanetwork
Ipamorelin enhances GH secretion without raising cortisol or prolactin, making it safer than earlier GHRP options.
Source: wikipedia